PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 256 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,297,293 | -20.5% | 105,300 | -24.8% | 0.58% | -26.1% |
| Q4 2022 | $5,407,331 | -27.4% | 140,050 | 0.0% | 0.79% | -51.4% |
| Q3 2022 | $7,449,000 | -22.2% | 140,050 | -14.7% | 1.62% | -10.8% |
| Q2 2022 | $9,576,000 | -24.7% | 164,250 | -1.5% | 1.82% | +7.3% |
| Q1 2022 | $12,721,000 | +8.4% | 166,675 | -14.5% | 1.70% | +79.0% |
| Q4 2021 | $11,733,000 | +19.7% | 195,000 | +11.4% | 0.95% | +39.3% |
| Q3 2021 | $9,802,000 | -6.4% | 175,038 | +1.4% | 0.68% | +7.9% |
| Q2 2021 | $10,470,000 | -18.3% | 172,538 | -5.6% | 0.63% | -29.2% |
| Q1 2021 | $12,814,000 | +54.8% | 182,824 | +32.2% | 0.89% | +69.8% |
| Q4 2020 | $8,277,000 | +141.9% | 138,324 | +143.0% | 0.52% | +125.9% |
| Q3 2020 | $3,422,000 | +55.5% | 56,924 | +35.8% | 0.23% | 0.0% |
| Q2 2020 | $2,200,000 | – | 41,924 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |